Posted on December 30, 2015 by Sitemaster
A new study in JAMA Oncology has suggested that surgical orchiectomy may have lower risk for complications and side effects than medical castration with LHRH agonists (also known as GnRH agonists) like leuprolide acetate (Lupron) and others in treatment of men newly diagnosed with metastatic prostate cancer. This is a complex issue! … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: adverse effects, castration, medical, metastatic, orchiectomy, surgical | 11 Comments »
Posted on August 21, 2014 by Sitemaster
An article available in full on the Medscape web site provides an overview of short-term outcomes of > 43,000 men diagnosed with prostate cancer in France in 2009 and followed for 2 years based on data in the French national health insurance information system (SNIIRAM). You do need to register with Medscape to be able to read the article (but registration is free). … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Treatment | Tagged: adverse effects, Diagnosis, France, mortality, outcome | Leave a comment »
Posted on July 28, 2012 by Sitemaster
A recently reported study offers us data from a cohort of nearly 800 men in Norway, all diagnosed in 2004 with localized or locally advanced prostate cancer and then surveyed for quality of life in October 2006. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Treatment | Tagged: adverse effects, Norway, QOL, quality of life, Treatment | Leave a comment »
Posted on June 27, 2012 by Sitemaster
A new article just published by Taylor et al. in the Journal of Clinical Oncology provides detailed information about the persistence of clinically significant, long-term, prostate cancer-specific, treatment-related sexual and urinary adverse effects up to 10 years post-diagnosis. Coverage of this article also appears in a report on Reuters.com. … READ MORE …
Filed under: Living with Prostate Cancer, Management | Tagged: adverse effects, long-term, persistence, Treatment | 5 Comments »
Posted on October 28, 2011 by Sitemaster
According to new data presented at the Frontiers in Cancer Prevention Research meeting ongoing this week in Boston, MA, some 70 percent of prostate cancer patients participating in a survey in Michigan reported long-term, treatment-related, adverse effects after first-line treatment with surgery or radiation therapy. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: adverse effects, follow-up, lontg-term, radiation, surgery | 6 Comments »
Posted on August 11, 2011 by Sitemaster
In 1989 the Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4) started randomizing men with a clinically initiated diagnosis of localized prostate cancer to either watchful waiting or open radical prostatectomy as their primary treatment. A new paper has now addressed the long-term quality of life (QoL) of men in this study. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: adverse effects, outcome, quality of life, radical prostatectomy, Scandinavian, SPCG-4, trial, watchful waiting | Leave a comment »
Posted on December 22, 2010 by Sitemaster
The adverse effects of androgen deprivation therapy (ADT) resulting from the use of surgical castration (orchiectomy) or medical castration (luteinizing hormone-releasing hormone [LHRH] agonists) are extensive, including sexual dysfunction, hot flashes, osteoporosis, and many others. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: ADT, adverse effects, androgen deprivation, estogen | Leave a comment »
Posted on December 22, 2010 by Sitemaster
Prospective data from a significant Spanish study provide us with additional insights into the short- and longer-term adverse effects of common types of invasive therapy for localized prostate cancer. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: adverse effects, external beam radiation, first line, radical prostatectomy, surgery | 2 Comments »
Posted on November 3, 2010 by Sitemaster
Two new studies just posted on line in the Journal of Clinical Oncology specifically address some of the adverse effects associated with 12 months of continuous androgen deprivation therapy (ADT) in men with non-metastatic prostate cancer. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: ADT, adverse effects, androgen deprivation therapy, cognitive, function, physicial | 9 Comments »
Posted on October 28, 2010 by Sitemaster
Soy isoflavones are known to have antioxidant and anti-inflammatory activities and to sensitize prostate cancer cells to radiation therapy. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: adverse effects, complications, isoflavone, radiation therapy, soy | 1 Comment »
Posted on August 4, 2008 by Sitemaster
In 1996, the U.S. Preventive Services Task Force (U.S. PSTF) first issued a report stating that the benefits of screening for prostate cancer were far outweighed by the risks. This report was updated in 2002.
As of today, Tuesday August 5, 2008, the U.S. PSTF has issued another updated version of their guidelines on this subject … and they are still of the opinion that the potential risks of screening far outweigh the potential benefits. … MORE …
Filed under: Diagnosis, Tips | Tagged: adverse effects, benefit, Diagnosis, early detection, risk, screening | 11 Comments »
THE "NEW" PROSTATE CANCER INFOLINK 